Bausch Health Cos Operating Margin 2010-2023 | BHC
Current and historical operating margin for Bausch Health Cos (BHC) over the last 10 years. The current operating profit margin for Bausch Health Cos as of December 31, 2023 is 14.55%.
| Bausch Health Cos Operating Margin Historical Data |
| Date |
TTM Revenue |
TTM Operating Income |
Operating Margin |
| 2023-12-31 |
$8.76B |
$0.96B |
11.00% |
| 2023-09-30 |
$8.54B |
$0.37B |
4.33% |
| 2023-06-30 |
$8.35B |
$0.60B |
7.19% |
| 2023-03-31 |
$8.15B |
$0.35B |
4.28% |
| 2022-12-31 |
$8.12B |
$0.45B |
5.59% |
| 2022-09-30 |
$8.13B |
$1.07B |
13.10% |
| 2022-06-30 |
$8.19B |
$1.40B |
17.03% |
| 2022-03-31 |
$8.33B |
$0.96B |
11.58% |
| 2021-12-31 |
$8.43B |
$0.45B |
5.34% |
| 2021-09-30 |
$8.45B |
$0.08B |
0.92% |
| 2021-06-30 |
$8.48B |
$-0.04B |
-0.42% |
| 2021-03-31 |
$8.04B |
$0.21B |
2.57% |
| 2020-12-31 |
$8.03B |
$0.68B |
8.42% |
| 2020-09-30 |
$8.04B |
$-0.40B |
-4.91% |
| 2020-06-30 |
$8.11B |
$-0.53B |
-6.49% |
| 2020-03-31 |
$8.60B |
$-0.24B |
-2.81% |
| 2019-12-31 |
$8.60B |
$-0.20B |
-2.36% |
| 2019-09-30 |
$8.50B |
$0.90B |
10.57% |
| 2019-06-30 |
$8.43B |
$0.69B |
8.14% |
| 2019-03-31 |
$8.40B |
$0.18B |
2.19% |
| 2018-12-31 |
$8.38B |
$-2.38B |
-28.45% |
| 2018-09-30 |
$8.42B |
$-2.73B |
-32.43% |
| 2018-06-30 |
$8.51B |
$-2.81B |
-33.04% |
| 2018-03-31 |
$8.61B |
$-2.39B |
-27.76% |
| 2017-12-31 |
$8.72B |
$0.10B |
1.17% |
| 2017-09-30 |
$8.96B |
$0.57B |
6.40% |
| 2017-06-30 |
$9.22B |
$-0.33B |
-3.55% |
| 2017-03-31 |
$9.41B |
$-0.42B |
-4.47% |
| 2016-12-31 |
$9.67B |
$-0.57B |
-5.85% |
| 2016-09-30 |
$10.03B |
$-0.55B |
-5.47% |
| 2016-06-30 |
$10.34B |
$0.76B |
7.37% |
| 2016-03-31 |
$10.65B |
$1.02B |
9.61% |
| 2015-12-31 |
$10.45B |
$1.53B |
14.63% |
| 2015-09-30 |
$9.91B |
$1.97B |
19.83% |
| 2015-06-30 |
$9.18B |
$2.20B |
23.98% |
| 2015-03-31 |
$8.49B |
$2.22B |
26.09% |
| 2014-12-31 |
$8.21B |
$2.00B |
24.38% |
| 2014-09-30 |
$8.05B |
$1.62B |
20.13% |
| 2014-06-30 |
$7.53B |
$0.04B |
0.58% |
| 2014-03-31 |
$6.59B |
$-0.17B |
-2.58% |
| 2013-12-31 |
$5.77B |
$-0.41B |
-7.11% |
| 2013-09-30 |
$4.63B |
$-0.73B |
-15.82% |
| 2013-06-30 |
$3.97B |
$0.19B |
4.76% |
| 2013-03-31 |
$3.69B |
$0.14B |
3.66% |
| 2012-12-31 |
$3.48B |
$0.08B |
2.27% |
| 2012-09-30 |
$3.21B |
$0.17B |
5.32% |
| 2012-06-30 |
$2.93B |
$0.25B |
8.67% |
| 2012-03-31 |
$2.72B |
$0.29B |
10.49% |
| 2011-12-31 |
$2.43B |
$0.30B |
12.32% |
| 2011-09-30 |
$2.29B |
$0.26B |
11.18% |
| 2011-06-30 |
$1.90B |
$0.02B |
0.95% |
| 2011-03-31 |
$1.53B |
$-0.05B |
-3.34% |
| 2010-12-31 |
$1.18B |
$-0.11B |
-9.31% |
| 2010-09-30 |
$0.91B |
$-0.00B |
-0.22% |
| 2010-06-30 |
$0.91B |
$0.18B |
19.93% |
| 2010-03-31 |
$0.87B |
$0.14B |
16.59% |
| 2009-12-31 |
$0.82B |
$0.18B |
22.17% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$3.128B |
$8.757B |
|
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
|
